Ophthotech Corporation (NASDAQ:OPHT) last traded at $2.67 with shares seeing a daily low of $2.55 and high of $2.76. This difference between the high and low distinguishes the stock as one of the most volatile of the day.
It is among the market’s biggest gainers. Shares of the company are trading at $2.67 just a bit lower than $2.73, the 50 day moving average and a bit lower than the 200 day moving average of $2.83. The 50 day moving average went down $-0.06 or -2.20% whereas the 200 day average was down by -5.81%.
Traders are more bearish on shares of Ophthotech Corporation if you pay attention to the increase in short interest. The stock realized a rise in short interest between August 15, 2017 and August 31, 2017 of 3.59%. Short interest increased from 2,612,584 to 2,706,269 over that period. Days to cover decreased 0.0 to 5.0 and the percentage of shorted shares is 0.08% as of August 31. As of the latest earnings report the EPS was $-5.39 and is estimated to be $0.29 for the current year with 35,942,000 shares outstanding. Analysts expect next quarter’s EPS will be $-0.71 with next year’s EPS anticipated to be $-2.21.
Ophthotech Corporation, launched on January 5, 2007, is a biopharmaceutical company. The Company is involved in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the retina, known as the macula, that may result in blindness. Its product candidates include Fovista and Zimura..